New perspectives in clinical oncology from angiogenesis research
- 1 December 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (14), 2534-2539
- https://doi.org/10.1016/s0959-8049(96)00423-6
Abstract
No abstract availableThis publication has 44 references indexed in Scilit:
- Activation of tumor cell integrin α v β 3 controls angiogenesis and metastatic growth in the brainProceedings of the National Academy of Sciences, 2009
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Oncogenes and cell deathCurrent Opinion in Genetics & Development, 1994
- Analysis of experimental antiangiogenic therapyJournal of Pediatric Surgery, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growthNature, 1990
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989